PIGNet2, a versatile protein–ligand interaction prediction model that performs well in both molecule identification and optimization, demonstrates its potential in early-stage drug discovery.
No takes yet. Share an insight, caveat, or question.
Moon et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: